Nachrichten zur MERCK KGAA O.N. Aktie

dpa-AFX: Jefferies belässt Merck KGaA auf Buy - Ziel 188 Euro

NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Merck KGaA auf "Buy" mit einem Kursziel von 188…

Merck KGaA-Aktie mit leichten Kursgewinnen (142,00 €)

An der deutschen Börse notiert das Wertpapier von Merck aktuell etwas fester. Das Wertpapier kostete zuletzt 142,00 Euro. Ein Wertanstieg…

Bioprocess Bags Market revenue to hit USD 23 Billion by 2036, says Research Nester

Major bioprocess bags market players include Sartorius AG, Danaher Corporation, Merck KGaA, CellBios Healthcare and Lifesciences Pvt Ltd., Saint-Gobain, Corning…

dpa-AFX: JPMorgan belässt Merck KGaA auf Overweight - Ziel 190 Euro

NEW YORK (dpa-AFX Analyser) - JPMorgan hat die Einstufung für Merck KGaA nach einer Branchenkonferenz der US-Bank auf "Overweight" mit einem…

Merck (MRK) to Strengthen Cancer Pipeline With Harpoon Buyout

Mercks (MRK) Harpoon buyout is expected to strengthen its oncology pipeline by adding the latters lead pipeline candidate, HPN328, a…

Merck on track to snap its seven-day win streak

…

Mercks Soaring Stock: Examining The Euphoria Amidst Potential Pitfalls

…

Merck to Buy Harpoon Therapeutics for $680 Million

…

Merck to buy Harpoon Therapeutics for $680 million By Reuters

Merck to buy Harpoon Therapeutics for $680 million…

Harpoon Therapeutics doubles on report Merck nears takeover By Investing.com

Harpoon Therapeutics doubles on report Merck nears takeover…

Merck close to acquiring cancer specialist Harpoon Therapeutics

Merck & Co Inc (NYSE:MRK) is close to acquiring Harpoon Therapeutics Inc, a cancer drug developer, for about $700 million to…

Desaster bei Boeing, Merck will Harpoon Therapeutics und Reserve Split bei Qiagen - BÖRSE TO GO

Die Reihe der Desaster bei Boeing will nicht abreißen. Der Abriss einer Tür mitten im Flug einer Boeing Max Maschine…

Merck in talks to acquire Harpoon Therapeutics for around $700M - Bloomberg

…

Merck reportedly in talks to buy drugmaker for more than double Friday’s price

…

Merck (MRK) Begins Pivotal Studies on Four Cancer Candidates

Merck (MRK) begins global pivotal studies on bomedemstat, nemtabrutinib, MK-2870 and MK-5684.…

Merck looks to tap into obesity drug market

…

Top Analyst Reports for Merck, Salesforce & Philip Morris

Todays Research Daily features new research reports on 16 major stocks, including Merck & Co., Inc. (MRK), Salesforce, Inc. (CRM)…

Pfizer and Illumina downgraded but Merck can deliver, declares TD Cowen By Investing.com

Pfizer and Illumina downgraded but Merck can deliver, declares TD Cowen…

Merck stock poised for sixth straight gain

…

JEFFERIES stuft MERCK KGAA auf Buy

NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Merck KGaA auf "Buy" mit einem Kursziel von…

dpa-AFX: Jefferies belässt Merck KGaA auf Buy - Ziel 188 Euro

NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Merck KGaA auf "Buy" mit einem Kursziel von 188…

C4 Therapeutics (CCCC) Gains 310% in 3 Months: Heres Why

C4 Therapeutics (CCCC) shares surge on a licensing deal to develop degrader-antibody conjugates with Merck and positive data from CFT7455…

Moderna Stock Is Climbing Thanks to Merck, But Is It Still a Buy?

The pairs collaboration is making waves, and theres more to come.…

Treffer +33%! Merck Aktie hat Erholungskurs eingeschlagen!

Kaufsignal und Widerstand sind geschafft. Diejenigen unserer Abonnenten, die uns Ihr Vertrauen geschenkt hatten und zu unserem genannten Einstiegskurs mit…

LEG Immobilien, PNE, Bayer, Merck, Tomra, Block: Was sind Knockout-Hebel-Zertifikate und wie ...

Bei Knockout-Hebel-Zertifikaten wird auf einen bestimmten Wert gesetzt, für den es einen bestimmten Hebel und einen definierten Knockout-Kurs gibt, der…

Merck (MRK) & Daiichi Sankyos Lung Cancer ADC Gets Priority Tag

Merck (MRK) and Daiichi Sankyos regulatory filing for HER3-DXd gets the FDAs priority review grant for the treatment of adult…

Merck: Smart Value For Potentially Strong Total Returns

…

Merck: An Excellent Dividend Grower With Strong Annual Total Return Potential

…

Merck: One Of The Best - Unveiling The Trifecta Of Safety, Dividends, And Growth

…

Is Merck & Co., Inc.s (NYSE:MRK) Recent Stock Performance Tethered To Its Strong Fundamentals?

Merck (NYSE:MRK) has had a great run on the share market with its stock up by a significant 5.7% over…

Pharma Stock Roundup: FDA Nod to AZNs Eplontersen, CRL to MRKs Cough Candidate

FDA approves AstraZeneca (AZN) and Ionis (IONS) Wainua (eplontersen) for ATTRv-PN and gives CRL to Mercks chronic cough candidate, gefapixant.…

Global Downstream Processing Market Size worth USD 109.1 Billion by 2032 | CAGR of 14.8%

The Global Downstream Processing Market Size was valued at USD 27.45 Billion in 2022 and the Worldwide Downstream Processing Market…

Merck: Im nächsten Jahr dann wieder vorne mit dabei?

Während der DAX 2023 ein überdurchschnittlich starkes Börsenjahr ausweisen wird, gehört eine Aktie, die den Index in den letzten zehn…

Mercks (MRK) Chronic Cough Drug Gets Another CRL From FDA

Per the FDA, the data submitted by Merck (MRK) for its chronic cough drug did not provide sufficient evidence to…

FDA Accepts Mercks (MRK) BLA for 21-Valent Pneumococcal Jab

The FDA grants priority review to Mercks (MRK) filing seeking approval for its 21-valent pneumococcal conjugate vaccine in adults. A…

Better Dividend Stock: Bristol Myers Squibb or Merck? @themotleyfool #stocks $BMY $MRK $^GSPC

These two pharma stocks have sizable dividend yields. Which is the better buy right now?…

Better Dividend Stock: Bristol Myers Squibb or Merck?

These two pharma stocks have sizable dividend yields. Which is the better buy right now?…

Merck: Hochstufung

London (www.aktiencheck.de) - Rating-Update: Die Analysten von HSBC stufen die Aktie der Merck KGaA (ISIN: DE0006599905, WKN: 659990, Ticker-Symbol: MRK) von…

Merck: Merckliche Rückschläge - Rating gesenkt - Aktienanalyse

Wien (www.aktiencheck.de) - Merck-Aktienanalyse von der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), stuft die…

Pfizer (PFE) Stock Rises on FDA Nod for Expanded Use of Padcev

The FDA approves Pfizers (PFE) Padcev in combination with Mercks (MRK) Keytruda for adult patients with advanced bladder cancer. Stock…

Merck (MRK) Gets EU Nod for Expanded Use in Gastric Cancer

Following these approvals, Mercks (MRK) Keytruda is approved for seven gastrointestinal cancers in the European Union. Overall, the drug is…

Global Myasthenia Gravis Treatment Market Forecast and Trends 2023-2028, Featuring Profiles of AbbVie, Bausch Health, Gilead Sciences, Merck, Servier and Teva

Dublin, Dec. 18, 2023 (GLOBE NEWSWIRE) -- The "Global Myasthenia Gravis Treatment Market: Forecast and Trends" report has…

dpa-AFX ProFeed